Total Payments
$347.88
2024 Payments
$147.42
Companies
15
Transactions
17
Medicare Patients
2,210
Medicare Billing
$479,306
Payment Breakdown by Category
Food & Beverage$245.31 (70.5%)
Education$102.57 (29.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $245.31 | 12 | 70.5% |
| Education | $102.57 | 5 | 29.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $52.79 | 2 | $0 (2024) |
| AbbVie Inc. | $40.07 | 2 | $0 (2021) |
| Sumitomo Pharma America, Inc. | $23.93 | 1 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $23.91 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $23.44 | 1 | $0 (2022) |
| ARRAY BIOPHARMA INC | $22.80 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $22.08 | 1 | $0 (2024) |
| SOBI, INC | $21.55 | 1 | $0 (2024) |
| PUMA BIOTECHNOLOGY, INC. | $20.94 | 1 | $0 (2021) |
| Daiichi Sankyo Inc. | $19.96 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $147.42 | 6 | PFIZER INC. ($39.99) |
| 2023 | $54.56 | 3 | Sumitomo Pharma America, Inc. ($23.93) |
| 2022 | $72.97 | 4 | Novartis Pharmaceuticals Corporation ($23.44) |
| 2021 | $72.93 | 4 | AbbVie Inc. ($40.07) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Rare Disease | ||||||
| 09/05/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $19.93 | General |
| 05/10/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 03/28/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Oncology | ||||||
| 01/08/2024 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $39.99 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $15.01 | General |
| Category: Oncology | ||||||
| 09/06/2023 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Oncology | ||||||
| 06/28/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Education | In-kind items and services | $23.93 | General |
| Category: HORMONE THERAPY | ||||||
| 09/13/2022 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, PAXLOVID | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: ONCOLOGY | ||||||
| 04/20/2022 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $12.80 | General |
| Category: ONCOLOGY | ||||||
| 04/12/2022 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: ONCOLOGY | ||||||
| 03/16/2022 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Education | In-kind items and services | $13.93 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 05/11/2021 | PUMA BIOTECHNOLOGY, INC. | NERLYNX (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: ONCOLOGY | ||||||
| 03/18/2021 | AbbVie Inc. | ORIAHNN (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: WOMENS HEALTH | ||||||
| 02/25/2021 | AbbVie Inc. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 582 | 1,518 | $377,648 | $162,144 |
| 2022 | 5 | 608 | 1,363 | $355,071 | $122,243 |
| 2021 | 5 | 495 | 1,322 | $296,700 | $119,247 |
| 2020 | 6 | 525 | 1,340 | $197,083 | $75,671 |
Total Patients
2,210
Total Services
5,543
Medicare Billing
$479,306
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 150 | 606 | $171,158 | $76,152 | 44.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 274 | 615 | $125,623 | $53,849 | 42.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 50 | 184 | $40,112 | $15,928 | 39.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 73 | 73 | $23,755 | $11,366 | 47.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 40 | $17,000 | $4,849 | 28.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 153 | 552 | $150,360 | $56,682 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 251 | 506 | $124,982 | $33,816 | 27.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 34 | 123 | $26,814 | $9,493 | 35.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 69 | 69 | $18,781 | $8,896 | 47.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 29 | 38 | $10,625 | $4,918 | 46.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 47 | $11,609 | $4,319 | 37.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 25 | 28 | $11,900 | $4,118 | 34.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 127 | 582 | $160,162 | $61,765 | 38.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 260 | 592 | $96,951 | $40,764 | 42.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 55 | 55 | $14,760 | $7,793 | 52.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 31 | 71 | $15,478 | $5,507 | 35.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 22 | 22 | $9,350 | $3,419 | 36.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 333 | 1,052 | $144,186 | $56,436 | 39.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 39 | 114 | $24,852 | $8,649 | 34.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 52 | 52 | $12,747 | $4,414 | 34.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 21 | 22 | $9,350 | $2,950 | 31.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 48 | 62 | $4,408 | $2,469 | 56.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2020 | 32 | 38 | $1,540 | $752.61 | 48.9% |
About Dr. Thy Nguyen, M.D
Dr. Thy Nguyen, M.D is a Hematology & Oncology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053352112.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thy Nguyen, M.D has received a total of $347.88 in payments from pharmaceutical and medical device companies, with $147.42 received in 2024. These payments were reported across 17 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($245.31).
As a Medicare-enrolled provider, Nguyen has provided services to 2,210 Medicare beneficiaries, totaling 5,543 services with total Medicare billing of $479,306. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Oklahoma City, OK
- Active Since 06/09/2006
- Last Updated 11/10/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1053352112
Products in Payments
- XTANDI (Drug) $39.99
- ORGOVYX (Drug) $23.93
- ULTOMIRIS (Biological) $23.91
- LUTATHERA (Drug) $23.44
- BRAFTOVI (Drug) $22.80
- RYBREVANT (Drug) $22.08
- DOPTELET (Drug) $21.55
- NERLYNX (Drug) $20.94
- ORILISSA (Drug) $20.73
- Enhertu (Drug) $19.96
- ORIAHNN (Drug) $19.34
- PADCEV (Biological) $15.62
- OPDIVO (Biological) $15.01
- BELEODAQ (Drug) $13.93
- IBRANCE (Drug) $12.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Oklahoma City
Robert Reynolds, Md, MD
Hematology & Oncology — Payments: $14,579
Hematology & Oncology $14,579
Philip Comp, Md, MD
Hematology & Oncology — Payments: $13,151
Hematology & Oncology $13,151
Dr. Charles Hollen, M.d, M.D
Hematology & Oncology — Payments: $12,135
Hematology & Oncology $12,135
Jennifer Holter-Chakrabarty, Md, MD
Hematology & Oncology — Payments: $11,994
Hematology & Oncology $11,994
Dr. Saadia Chohan, Md, MD
Hematology & Oncology — Payments: $11,197
Hematology & Oncology $11,197
Abby Bova, Md, MD
Hematology & Oncology — Payments: $5,791
Hematology & Oncology $5,791